Product Name 産(chǎn)品名(míng)稱 | Niacin Extended-Release Tablets 煙酸緩釋片 |
Strength 規格 | 500 mg 1,000 mg |
Product License | ANDA #214428 |
Indications 适應症 | • To reduce elevated TC, LDL-C, Apo B and TG, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia. • To reduce TG in adult patients with severe hypertriglyceridemia. •降低原發性高脂血症和混合性血脂異常患者的TC、LDL-C、Apo B和TG升高，并增加HDL-C。 •降低患有(yǒu)嚴重高甘油三酯血症的成年患者的TG。 |
Approved Date 批準日期 | 11/22/2021 |
Market Authorization Holder 持有(yǒu)人 | Beijing Sciecure Pharmaceutical Co., Ltd. 北京世橋生物(wù)制藥有(yǒu)限公(gōng)司 |
Manufacture 生産(chǎn)商(shāng) | Beijing Sciecure Pharmaceutical Co., Ltd. 北京世橋生物(wù)制藥有(yǒu)限公(gōng)司 |